This review presents evidence that the C-X-C motif chemokine receptor 3 (CXCR3) axis and its ligands, CXCL9, CXCL10, and CXCL11, serve as crucial coordinators of immune responses in viral hemorrhagic fever diseases. We delineated the biology of CXCR3 and its expression in Th1, Th17.1, T follicular helper, regulatory T, cytotoxic CD8 T, and natural killer cells. Additionally, we summarized the role of interferon-mediated gradients of CXCL9, CXCL10, and CXCL11 in the recruitment and programming of these effector cells within inflamed tissues. Research involving both human and animal subjects has consistently associated elevated CXCL9/10/11 signaling with disease activity, endothelial dysfunction, and clinical outcomes. Experimental models have further elucidated that these signals can exert both protective and detrimental effects depending on factors such as timing, tissue compartment, and cell type. Proof-of-concept interventions demonstrate the greatest efficacy in dengue disease models, where modulation of this pathway results in reduced viral replication, restoration of type I interferon functions, improvement in hematologic parameters, and limitation of vascular leakage. In various hemorrhagic fevers, convergent transcriptomic and proteomic signatures identify the pathway as a viable target and source of dynamic biomarkers for risk stratification and response monitoring. Collectively, the CXCR3 axis emerged as a unifying mechanism and is a promising intervention for controlling viral hemorrhagic fever.